Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Study finds high glucose level blocks infectious bacteria detection, affects immunity

Research led by the Warwick Medical School at the University of Warwick has found that unhealthy glucose levels in patients with diabetes can cause significantly more problems for the body than just the well-known symptoms of the disease such as kidney damage and circulation problems.

24 Aug 2010

Measles outbreak in northern NSW and Queensland

There is a confirmed measles outbreak just south of the Queensland border according to Queensland Health authorities. There have been seven cases of this highly infectious disease at Tweed Heads, NSW, including a person who reportedly visited a McDonald’s restaurant at Coolangatta over the weekend. Any residents who visited the fast food outlet between 8am and 1pm on Saturday are advised to check their vaccination status.

23 Aug 2010

Publix Super Markets to introduce flu immunization program

"Flu clinics are an extension of the services our pharmacies provide to our customers as a convenient and affordable way to receive their vaccinations," said Maria Brous, Publix director of media and community relations. "At Publix, our pharmacies are dedicated to building relationships with our customers and their families for total health and wellness all year long."

23 Aug 2010

Flu vaccine to be available at local pharmacies, doctor's offices

Flu vaccine will soon be available at local pharmacies and doctor's offices, and government officials are urging everyone over 6 months of age to receive it. This year's vaccine protects against H1N1 and two other strains of seasonal flu.

23 Aug 2010

HHS Secretary releases review of new federal approach to medical countermeasures

U.S. Department of Health and Human Services Secretary Kathleen Sebelius today released an examination of the federal government's system to produce medications, vaccines, equipment and supplies needed for a health emergency, known as medical countermeasures. The Public Health Emergency Medical Countermeasure Enterprise Review: Transforming the Enterprise to Meet Long Range National Needs reviews the process and makes recommendations for a better approach.

21 Aug 2010

Immunization rate increases among teens: NIS report

In light of today's report of the National Immunization Survey results, the Society for Adolescent Health and Medicine (SAHM) encourages increased efforts in fully immunizing all adolescents.

21 Aug 2010

HHS unveils $1.9B strategy to better prepare for biological threats

"Acknowledging that the development of medical countermeasures against bioterrorism threats and pandemic flu is lagging, [U.S.] federal authorities Thursday announced a $1.9 billion makeover of the system for identifying and manufacturing drugs and vaccines for public-health emergencies," Tribune Company/Seattle Times reports.

21 Aug 2010

Scientists identify compound to treat Chagas' disease

A new compound may offer an effective drug candidate against the deadly tropical infection, Chagas' disease say researchers from Brazil. They report their findings in the August 2010 issue of the journal Antimicrobial Agents and Chemotherapy.

21 Aug 2010

Feds to revamp bioterrorism and flu plans

Federal officials say they will revamp strategies for dealing with bioterrorism and pandemic flu because efforts to develop medical solutions have lagged, the Los Angeles Times reports. They "announced a $1.9-billion makeover of the system for identifying and manufacturing drugs and vaccines for public health emergencies." The makeover includes plans to hasten manufacturing time and improve surveillance to detect such threats more quickly.

21 Aug 2010

Tips for management of COPD

What is the fourth leading cause of death in the United States? Many would be surprised to learn that chronic obstructive pulmonary disease (COPD) is, and the number of people with COPD is increasing. According to the COPD Foundation, more than 12 million Americans are currently diagnosed with COPD and an additional 12 million may not realize their shortness of breath and coughing are in fact symptoms of this debilitating condition.

20 Aug 2010

First Edition: August 20, 2010

Today's headlines include articles on health insurance for college students, new plans to overhaul the government's bioterror and flu preparations, changes in store for health care for the homeless and a look at the new high risk insurance plans.

20 Aug 2010

Tasigna receives approval for chronic myeloid leukemia in Canada

Tasigna (nilotinib) capsules have been approved with conditions in Canada as a new therapy for patients with CML, in the chronic phase (first phase) of the disease. Patients must be resistant to or intolerant of at least one prior therapy, including (Pr)Gleevec (imatinib mesylate), an established standard of care.

20 Aug 2010

Chicago-based pasteurized eggs producer increases production following recall of salmonella-infected eggs

Chicago-based National Pasteurized Eggs today ramped up production of its industry-leading salmonella-free Davidson's Safest Choice Pasteurized Shell Eggs as federal health officials expanded the recall of eggs linked to salmonella enteritidis to 380 million.

20 Aug 2010

New research could extend the life of donated organs

The fruit fly Drosophila melanogaster does boast a powerful genetic system making it an ideal organism to test a cool new discovery: how an enzyme regulates body energy levels. Shutting off this molecular thermostat could result in a newfound cold tolerance that has multiple applications, including extending the 24-hour window donated organs now have for optimum use.

20 Aug 2010

Celgene receives Japan's MHLW approval for REVLIMID in deletion 5q myelodysplastic syndrome patients

Celgene International Sàrl announced that REVLIMID (lenalidomide) has been granted full marketing authorization by Japan's Ministry of Health, Labour and Welfare (MHLW) for the treatment of patients with myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenic abnormality. REVLIMID was also approved in June 2010 in combination with dexamethasone, for the treatment of patients with relapsed or refractory multiple myeloma who have received at least one prior standard therapy.

20 Aug 2010

Research marks new direction to treat Pneumocystis, inflammatory diseases

A drug to treat inflammation plays a surprising role reducing the level of infection caused by an opportunistic bug that is deadly for AIDS and cancer patients and others with weakened immune systems.

20 Aug 2010

Scientists suggest combination vaccine prevents pertussis

If you think you shouldn't be worried about your child's—or your—lingering, nagging cough, think again. Pertussis has reemerged on the scene. In what some public health officials are calling the worst outbreak in 50 years, pertussis, better known by its unique sound—whooping cough, has been found in six states with 1,500 cases reported, six of them fatal.

19 Aug 2010

PAREXEL International launches temperature recording solution optimized for clinical trial supply process

PAREXEL International Corporation, a leading global biopharmaceutical services organization, today announced that it has introduced an integrated temperature recording solution for study drug transportation as part of its expanded Clinical Logistics Services.

From Parexel 19 Aug 2010

General Physics to provide AAR/IP to gauge overall response to H1N1 outbreak

Global performance improvement solutions provider General Physics Corporation, a subsidiary of GP Strategies Corporation, has been selected by the Maryland Department of Public Health and Mental Hygiene to provide an After Action Report/Improvement Plan for the 2009 response to the H1N1 virus. GP will collect data from public health entities in order to gauge the overall response to the H1N1 outbreak and lessons learned, for DHMH to evaluate and consider for future pandemic response.

19 Aug 2010

Montana State University offers new biomedical technologies for prevention, treatment of viral infections

Researchers at Montana State University have developed six new biomedical technologies that could have applications for treating antibiotic resistant infections, fungal infections and viral infections; boosting humans' innate immunity and improving scientists' ability to study such compounds. The technologies are available for licensing to interested companies and entrepreneurs.

19 Aug 2010

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Study finds high glucose level blocks infectious bacteria detection, affects immunity

Measles outbreak in northern NSW and Queensland

Publix Super Markets to introduce flu immunization program

Flu vaccine to be available at local pharmacies, doctor's offices

HHS Secretary releases review of new federal approach to medical countermeasures

Immunization rate increases among teens: NIS report

HHS unveils $1.9B strategy to better prepare for biological threats

Scientists identify compound to treat Chagas' disease

Feds to revamp bioterrorism and flu plans

Tips for management of COPD

First Edition: August 20, 2010

Tasigna receives approval for chronic myeloid leukemia in Canada

Chicago-based pasteurized eggs producer increases production following recall of salmonella-infected eggs

New research could extend the life of donated organs

Celgene receives Japan's MHLW approval for REVLIMID in deletion 5q myelodysplastic syndrome patients

Research marks new direction to treat Pneumocystis, inflammatory diseases

Scientists suggest combination vaccine prevents pertussis

PAREXEL International launches temperature recording solution optimized for clinical trial supply process

General Physics to provide AAR/IP to gauge overall response to H1N1 outbreak

Montana State University offers new biomedical technologies for prevention, treatment of viral infections

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Newsletters you may be interested in